|
Keltech Energies
|
506528 |
07-Jul-25 |
Inter alia to: 1. Consider and approve the Appointment of Mr. Satish Vasant Ghatge (DIN: 00329266) as an Additional Non-Executive - Independent Director of the Company. 2. Consider and approve the Appointment of Mr. Vasudev Narayan Tumbe (DIN: 10667983) as an Additional Non-Executive - Independent Director of the Company. 3. Approval for Revised draft notice of 48tt Annual General Meeting originally approved in the Board Meeting held on 23" May 2025. 4. Approval for Revised draft Board Report originally approved in the Board Meeting held on 234 May 2025. 5. Any other business with the permission of Chair. |
|
Frontier Capital
|
508980 |
07-Jul-25 |
Frontier Capital Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 inter alia to consider and approve the proposal for fund raising through the issue of equity shares of the Company on Rights Basis to existing equity shareholders of the Company as may be permitted under applicable law subject to such regulatory and/or statutory approvals as may be applicable
The Board Meeting to be held on 07/07/2025 Stands Cancelled.
This is to inform you due to unavoidable circumstances, the meeting of board of
directors which was scheduled to be held on Monday, 7 July 2025 is now cancelled. The
Company will inform the revised date of the meeting, as and when finalized
(As per BSE Announcement Dated on 04/07/2025) |
|
Arihant Capital
|
511605 |
07-Jul-25 |
Preferential Issue of shares & Quarterly Results Inter alia, to consider and approve:- 1. Fund Raising by way of equity shares or other instruments or securities through permissible modes including QIP or any other permissible mode and/ or combination thereof as may be considered appropriate, subject to such statutory/ regulatory approvals, as applicable. 2. To approve the notice of the Extra-Ordinary General Meeting and Annual General Meeting of the shareholders for obtaining consent on necessary resolutions and matters. 3. Other incidental and ancillary matters. |
|
Arunis Abode
|
526935 |
07-Jul-25 |
Arunis Abode Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 inter alia to consider and approve To consider and approve fund rising through any permissible mode as the Board may deem appropriate. |
|
Esaar (India)
|
531502 |
07-Jul-25 |
Esaar India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/06/2025 inter alia to consider and approve The Audited Financial Result of the Company for the Quarter and year ended March 31 2025.
Esaar India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 ,inter alia, to consider and approve the Audited financial result for the quarter and year ended March 31, 2025
(As Per BSE Announcement Dated on:30.06.2025) |
|
Nectar Lifesci.
|
532649 |
07-Jul-25 |
Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the Financial Year 2024-25 Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto.
Please find attached herewith the reason for delay in financial results for the quarter and year ended on March 31, 2025.
Please find attached herewith change in Directors as per letter.
Further, please also be informed that the Audit Committee and Board of Directors could not approve and take on record the Audited Financial Results and Financial Statements for the quarter and year ended March 31, 2025. Therefore, the meetings stand adjourned sine die, for said matters. The reasons for delay in submission of financial results is being submitted by way of separate letter.
The date of adjourned Board Meeting shall be intimated in due course of time. The trading window closure period is being extended accordingly till 48 hours after the declaration of Financial Results for the period ended on March 31, 2025
(As per BSE Announcement Dated on 30/05/2025)
Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year 2024-25, Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto
(As Per BSE Announcement Dated on :03.07.2025) |